Nr. | Numelestudiului | Status | Locatia/Locatiilestudiului |
1 | A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma | In curs de recrutare | Local Institution, Bucharest, Romania, 022328, Contact: Site 0066 Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0070 Local Institution, Craiova, Romania, 200347, Contact: Site 0067 Local Institution, Lasi, Romania, 700483, Contact: Site 0069 |
2 | A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma | In curs de recrutare | Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0070 Local Institution, Craiova, Romania, 200347, Contact: Site 0071 Local Institution, Floresti, Romania, 407280, Contact: Site 0120 Local Institution, Oradea, Romania, 410469, Contact: Site 0073 |
3 | Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma (CheckMate76K) | In curs de recrutare | Local Institution, Bucharest, Romania, 020122, Contact: Site 0021 Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0047 Local Institution, Craiova, Romania, 200347, Contact: Site 0020 |
4 | An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma (CheckMate 915) | Activ, inca nu se recruteaza | Institute Of Oncology „Prof.Dr.Alexandru Trestioreanu” Bucharest, Bucharest, Romania, 022328Sf. Nectarie Oncology Center, Craiova, Romania, 200347 |
5 | Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma (CheckMate 238) | Activ, inca nu se recruteaza | Local Institution, Craiova, Romania, 200347Local Institution, Romania, Romania, 400015 |
6 | A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection | In curs de recrutare | Nova Clin Medical Research Center, Timisoara, Romania, 300696, Contact: Alexandru Bolocan, Site 0030 |
7 | Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630) | In curs de recrutare | Spitalul Universitar CF Cluj-Napoca ( Site 1103) RecruitingCluj-Napoca, Cluj, Romania, 400015, Contact: Study Coordinator +40724283983 S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1101), Craiova, Dolj, Romania, 200347, Contact: Study Coordinator +40727774974 S C Oncocenter Oncologie Medicala S R L (Site 1106), Timisoara, Timis, Romania, 300166, Contact: Study Coordinator +40745146020 Hifu Terramed Conformal SRL ( Site 1111), Bucharest, Romania, 031864, Contact: Study Coordinator +40723599588 S.C.Focus Lab Plus S.R.L ( Site 1107), Bucuresti, Romania, 021389, Contact: Study Coordinator +40721298677 Cardiomed SRL Cluj-Napoca ( Site 1104), Cluj-Napoca, Romania, 400015, Contact: Study Coordinator +40724543672 S C Pelican Impex SRL ( Site 1108), Oradea, Romania, 410450, Contact: Study Coordinator +40746103306 Policlinica Oncomed SRL ( Site 1105), Timisoara, Romania, 300239, Contact: Study Coordinator +40744571617 |
8 | A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) | Activ, inca nu se recruteaza | Centrul de Oncologie Sfantul Nectarie, Craiova, Dolj, Romania, 200347Oncolab SRL, Craiova, Dolj, Romania, 200385Medisprof SRL , Cluj-Napoca, Romania, 400461Clinical Emergency Hospital of Constanta, Constanta, Romania, 900591Center of Oncology Euroclinic, Iasi, Romania, 700106Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu, Romania, 550245Oncocenter – Oncologie Clinica SRL, Timisoara, Romania, 300166 |